La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Hercules Capital Gestione
Gestione criteri di controllo 2/4
Hercules Capital's Il CEO è Scott Bluestein, nominato in Apr2014, e ha un mandato di 10.33 anni. la retribuzione annua totale è $ 8.89M, composta da 7.3% di stipendio e 92.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.41% delle azioni della società, per un valore di $ 41.61M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.6 anni e 4.1 anni.
Informazioni chiave
Scott Bluestein
Amministratore delegato
US$8.9m
Compenso totale
| Percentuale dello stipendio del CEO | 7.3% |
| Mandato del CEO | 10.3yrs |
| Proprietà del CEO | 1.4% |
| Durata media del management | 5.6yrs |
| Durata media del Consiglio di amministrazione | 4.1yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Hercules Capital BDC: 10% Yield, Record Earnings
Aug 09Hercules Capital (NYSE:HTGC) Is Paying Out A Dividend Of $0.48
Aug 02
Hercules Capital: Recent Improvements But Currently Very Expensive
Jul 22Hercules Capital: 2 Possible Outcomes (Rating Downgrade)
Jul 08Hercules Capital: A Solid Dividend Stock But Valuation Concerns Are Valid
Jun 25Hercules Capital: A Premium Company, But Better To Wait Until Interest Rates Decrease
Jun 07Hercules Capital: Solid 10% Yield, But Sky-High Valuation
May 10Hercules Capital: VC-Focused Name With Less Risk And Better Return Prospects Than Average BDC
May 04Hercules Capital: Winning Option In The Financial Services Space
Apr 24There Is A Reason Hercules Capital, Inc.'s (NYSE:HTGC) Price Is Undemanding
Apr 22Hercules Capital: Record Year In 2023, 10% Yield
Mar 29Unlocking Hercules Capital's Income Potential: A Fresh Look At Dividend Timing Strategies
Feb 23Results: Hercules Capital, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 18Hercules Capital: Still Resilient With Solid Prospects Despite The VC Focus
Feb 17Hercules Capital: A Different Type Of VC-Focused BDC
Jan 16Hercules Capital Poised For Potential Market Surge In 2024
Dec 24Lacklustre Performance Is Driving Hercules Capital, Inc.'s (NYSE:HTGC) Low P/E
Dec 1810%-Yielding Hercules Capital: Better Ingredients, Better Outcomes
Dec 15Main Street Capital Vs. Hercules Capital: Why Choose?
Nov 22Hercules Capital: 10% Yield, My Largest BDC Position
Nov 1310%-Yielding Hercules Capital Is A BDC Superstar
Oct 10Hercules Capital: Venture Capital Financier Offering High Yield And Robust Balance Sheet
Sep 17Hercules Capital: 10% Yield, Strong Coverage, Low Leverage
Sep 09Let's Build A Bond Portfolio Together: Hercules Capital Bonds 2026 7.10%
Aug 15Hercules Capital: Fatter Yield, Surging Stock Price
Aug 05Hercules Capital: The Tide Is Turning - Buy While It's Cheap (Rating Upgrade)
Jun 28Hercules Capital raises dividend by 8.3% to $0.39/share, supplemental cash distribution of $0.08
Feb 14Hercules Capital: 2 Top Reasons To Buy This 10.1%-Yielding BDC
Jan 25Should You Buy Hercules Capital Before Or After Its Ex-Dividend Date?
Jan 11Hercules Capital: Bear Market Rally Fizzling Out
Dec 08Oak Street Health secures $300M in financing
Nov 16Hercules Capital: Double Your Cash Flow With This 10%+ Dividend
Nov 07Hercules Capital raises dividend by 2.9% to $0.36, supplemental cash distribution of $0.15
Oct 18Hercules Capital: Grab Its 13% Yield As Weak Holders Capitulate
Oct 03Hercules Capital: 10% Yield, Wake Up And Smell The Cash Flow
Aug 31Hercules Capital: 7% From An Investment Grade Bond With 4 Years To Maturity
Aug 23atai Life Sciences nabs $175M in loan facility from Hercules Capital
Aug 15Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$278m |
| Mar 31 2024 | n/a | n/a | US$331m |
| Dec 31 2023 | US$9m | US$650k | US$334m |
| Sep 30 2023 | n/a | n/a | US$277m |
| Jun 30 2023 | n/a | n/a | US$302m |
| Mar 31 2023 | n/a | n/a | US$197m |
| Dec 31 2022 | US$7m | US$650k | US$100m |
| Sep 30 2022 | n/a | n/a | US$42m |
| Jun 30 2022 | n/a | n/a | US$12m |
| Mar 31 2022 | n/a | n/a | US$105m |
| Dec 31 2021 | US$6m | US$650k | US$172m |
| Sep 30 2021 | n/a | n/a | US$319m |
| Jun 30 2021 | n/a | n/a | US$339m |
| Mar 31 2021 | n/a | n/a | US$318m |
| Dec 31 2020 | US$7m | US$650k | US$226m |
| Sep 30 2020 | n/a | n/a | US$120m |
| Jun 30 2020 | n/a | n/a | US$96m |
| Mar 31 2020 | n/a | n/a | US$83m |
| Dec 31 2019 | US$8m | US$594k | US$173m |
| Sep 30 2019 | n/a | n/a | US$111m |
| Jun 30 2019 | n/a | n/a | US$128m |
| Mar 31 2019 | n/a | n/a | US$132m |
| Dec 31 2018 | US$11m | US$515k | US$76m |
| Sep 30 2018 | n/a | n/a | US$111m |
| Jun 30 2018 | n/a | n/a | US$109m |
| Mar 31 2018 | n/a | n/a | US$90m |
| Dec 31 2017 | US$3m | US$500k | US$78m |
Compensazione vs Mercato: La retribuzione totale di Scott ($USD 8.89M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 6.76M ).
Compensazione vs guadagni: La retribuzione di Scott è aumentata di oltre il 20%, mentre gli utili aziendali sono diminuiti di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Scott Bluestein (46 yo)
10.3yrs
Mandato
US$8,891,994
Compensazione
Mr. Scott Bluestein is Miscellaneous of UBS Securities LLC. He is Chief Executive Officer, Chief Investment Officer, President and Director of Hercules Capital, Inc. He joined the Hercules Capital, Inc. in...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, Chief Investment Officer | 10.3yrs | US$8.89m | 1.41% $ 42.1m | |
| CFO & Chief Accounting Officer | 5.4yrs | US$3.04m | 0.21% $ 6.4m | |
| Chief Operating Officer | 8.6yrs | US$1.21m | 0.060% $ 1.8m | |
| Corporate Secretary | 2.6yrs | US$1.08m | 0.030% $ 894.3k | |
| Senior MD & Group Head of Technology | 5.6yrs | Nessun dato | Nessun dato | |
| Managing Director of Investor Relations & Corporate Communications | no data | Nessun dato | Nessun dato | |
| VP of Human Resources | 2.3yrs | Nessun dato | Nessun dato | |
| Managing Director | 20.3yrs | Nessun dato | Nessun dato | |
| Senior MD & Group Head of Life Sciences | 5.3yrs | Nessun dato | Nessun dato | |
| Managing Director of Portfolio Management | 5.6yrs | Nessun dato | Nessun dato | |
| Managing Director | 14.3yrs | Nessun dato | Nessun dato | |
| Managing Director | 5.6yrs | Nessun dato | Nessun dato |
5.6yrs
Durata media
52yo
Età media
Gestione esperta: Il team dirigenziale di HTGC è esperto e expertise (durata media dell'incarico 5.6 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, Chief Investment Officer | 5.1yrs | US$8.89m | 1.41% $ 42.1m | |
| Independent Director | 5.5yrs | US$215.00k | 0.037% $ 1.1m | |
| Chairman of the Board & Lead Independent Director | 18.4yrs | US$310.00k | 0.070% $ 2.1m | |
| Independent Director | 2.8yrs | US$250.00k | 0.010% $ 297.7k | |
| Independent Director | less than a year | US$39.99k | 0.0035% $ 104.7k | |
| Independent Director | 10.1yrs | US$205.00k | 0.062% $ 1.8m | |
| Independent Director | 3.1yrs | US$215.00k | 0.017% $ 492.8k | |
| Independent Board Directors | 2.2yrs | US$145.00k | 0.0086% $ 255.9k |
4.1yrs
Durata media
62.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di HTGC sono considerati esperti (durata media dell'incarico 4.1 anni).